# Mitochondrial Dysfunction and Insulin Resistance in Skeletal Muscle

> **NCT04558190** · NA · COMPLETED · sponsor: **University of Copenhagen** · enrollment: 10 (actual)

## Conditions studied

- Insulin Resistance

## Interventions

- **DRUG:** Intralipid, 20% Intravenous Emulsion
- **DIETARY_SUPPLEMENT:** MitoQ
- **DRUG:** Salbutamol

## Key facts

- **NCT ID:** NCT04558190
- **Lead sponsor:** University of Copenhagen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-02
- **Primary completion:** 2021-11-01
- **Final completion:** 2021-11-01
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2021-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04558190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04558190, "Mitochondrial Dysfunction and Insulin Resistance in Skeletal Muscle". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04558190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*